BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Berlin Heals Reports Positive First In Human Results For Less Invasive CMIC Therapy In Heart Failure

High Impact Session presented at Heart Rhythm Society's Congress in Chicago First time showing results of new Less Invasive approach Improvement in Lef...

April 27, 2026 | News

Ascletis Completes Enrollment For Phase II Study Of Oral GLP 1R Agonist ASC30 In Type 2 Diabetes

- 13-week U.S. Phase II study is evaluating the efficacy, safety and tolerability of oral small molecule GLP-1R agonist ASC30, a once-d...

April 27, 2026 | News

AscendCare Launches Public Initiative To Normalise Preventive Health Screenings

AscendCare Medical Clinic, a modern healthcare provider based in Tanjong Pagar, today announced a new public education initiative designed to reframe healt...

April 24, 2026 | News

Prestige Biopharma IDC Files Patent For Next Generation Subcutaneous Antibody Delivery Platform

Prestige Biopharma IDC, the innovative drug research institute of Prestige Biopharma, announced that it has filed a patent for 'IDC224,' a next-generation ...

April 24, 2026 | News

Everest Medicines Reports Promising First In Human Data For Personalised mRNA Cancer Vaccine EVM16

Everest Medicines announced that the first-in-human (FIH) clinical trial data of EVM16, a proprietary personalized mRNA cancer vaccine, were presen...

April 24, 2026 | News

Dayspring Pharma Reports Positive Phase II Results For CG2001 In Androgenetic Alopecia

Dayspring Pharma announced top-line data from its Phase II clinical trial of CG2001 foam in male patients with androgenetic alopecia (AGA). The trial ...

April 23, 2026 | News

Akamis Bio Reports Promising Early Efficacy For NG 350A In Rectal Cancer Study

NG-350A combined with chemoradiotherapy demonstrated promising efficacy and a favorable safety profile Composite response rate of 50 percent observed ac...

April 21, 2026 | News

EpiBiologics Advances Tissue Selective EGFR Degrader EPI 326 Into First In Human Clinical Study

First-in-human study of EPI-326 will evaluate the company’s lead tissue-selective EGFR degrader in patients with NSCLC and HNSCC with potential to ...

April 21, 2026 | News

Thermo Fisher Introduces PowerFlex Thermal Cycler To Simplify Complex PCR Workflows

A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible res...

April 17, 2026 | News

Mabwell Advances Alpha Synuclein PET Tracer Into Phase I Strengthening Early Diagnosis Of Neurodegenerative Disorders

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that 18F-FD4 (R&D code: SST0...

April 16, 2026 | News

Samsung Bioepis Initiates Phase 1 Clinical Trial for Novel ADC Candidate SBE303 Targeting Nectin 4

Samsung Bioepis Co., Ltd. announced the initiation of a Phase 1 clinical trial for SBE303, its first novel antibody drug conjugate candidate designed...

April 16, 2026 | News

Hoth Therapeutics Reports Positive HT VA Study Data Highlighting GDNF Driven Metabolic Reprogramming In Fatty Liver Disease

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, announced positive data from its HT-VA study, conducted unde...

April 15, 2026 | News

Caliway Secures Third Aesthetic Surgery Journal Recognition For CBL 514 Phase 2b Fat Reduction Study

Clinical results from Caliway's CBL-0204 Phase 2b study of its fat reduction drug candidate CBL-514 for localized fat reduction have been accepted by the...

April 15, 2026 | News

Thermo Fisher Scientific Partners HealthVerity To Advance Data Driven Clinical Development

Thermo Fisher Scientific, the world leader in serving science, announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) ...

April 14, 2026 | News

Stay Connected